Barclays’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40K | Buy |
7,035
+181
| +3% | +$1.03K | ﹤0.01% | 3979 |
|
|
2025
Q1 | $19K | Buy |
6,854
+728
| +12% | +$2.02K | ﹤0.01% | 4070 |
|
|
2024
Q4 | $42K | Buy |
6,126
+2,793
| +84% | +$19.1K | ﹤0.01% | 3982 |
|
|
2024
Q3 | $61K | Sell |
3,333
-2,237
| -40% | -$40.9K | ﹤0.01% | 3869 |
|
|
2024
Q2 | $106K | Hold |
5,570
| – | – | ﹤0.01% | 3349 |
|
|
2024
Q1 | $120K | Buy |
+5,570
| New | +$120K | ﹤0.01% | 3579 |
|